BFRI supply chain intelligence for Biofrontera Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
Biofrontera Inc. (BFRI) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| MIDAS-PHARMA-GMBH | MIDAS-PHARMA-GMBH | 92% | Among other things, the Supply Agreement provides that Midas will supply Discovery or its contract manufacturers, in the aggregate, 100 kg of the active pharmaceutical ingredient ("API") 5-Aminolevul… |
| BIOFRONTERA-PHARMA-GMBH | BIOFRONTERA-PHARMA-GMBH | 85% | Pursuant to the Second A&R Ameluz LSA, the price paid was set at twenty-five percent of the anticipated net selling price per unit through 2025 (the "Transfer Price") that covered the cost of goods, |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| BFRI-DEBT-8162 | Warrants outstanding: 100 | 90% | xbrl warrant detail from xbrl 2025-12-31. |
| BFRI-DEBT-8163 | Xbrl Convertible | 90% | xbrl convertible detail from xbrl 2024-12-31. |
| BFRI-DEBT | Debt stack $7.7M | 90% | Market cache reports total debt of $7.7M. |
| Holder | Name | Confidence | Evidence |
|---|---|---|---|
| BFRI-OWNER-ROSALIND-ADVISORS-INC | Rosalind Advisors, Inc. | 90% | 13F overlay lists Rosalind Advisors, Inc. as top holder; 12 tracked holders. |